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1. Introduction 
The C3b inactivator (C3bINA), in the presence of 
appropriate cofactors, catalyzes the proteolysis of the 
a’chains of C3b and C4b. This results in loss of the 
abilities of both proteins to participate in the cytol- 
ytic complement pathway, and inloss of their opsonic 
and immune adherence activities. The a’chain of C4b 
is cleaved in the presence of C4 binding protein, in 
two positions [ 1,2]. This yields a 45 OOOM, peptide 
(C4d,oz), which is released from the remainder of the 
molecule, and two peptides of 28 000 (CQ) and 18 000 
(a.+) Mr which remain disulfide-linked to the C4/3- and 
y-chains [l-4]. Hydrolysis of the of-chain of C3b 
occurs in the presence of fl1H globulin, and results in 
two peptides of 68 000 and 46 000 Mr [3,5,6]. Each 
of these fragments remains disulfide-bonded to the 
P-chain. The data in [7] indicate that the smaller pep- 
tide is further cleaved by the C3bINA to release a 
peptide of -3000Mr. 
The function of the C3bINA was first described in 
1967 [8-lo]. Studies since then have shown that the 
C3bINA is a glycoprotein composed of two disulfide- 
linked polypeptide chains of SO 000 and 40 000 Mr 
[2,3,11,12]. Although it seems certain that the 
C3bINA is a protease, it has not yet been possible to 
identify the class.of protease to which it belongs 
[7,12,13]. Here, I report the N-terminal amino acid 
sequences of the isolated C3bINA polypeptide chains. 
These data show that the N-terminal sequence of the 
light chain is characteristic of that of a serine protease. 
Abbreviations: C3bINA, C3b inactivator; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis; DFP, 
diisopropylphosphorofluoridate 
2. Materials and methods 
Isolation of the C3bINA was performed by modifi- 
cations of the methods in [2 ,141. Plasma was depleted 
of fibrinogen by precipitation with 10% sodium sul- 
fate at pH 7 .O; the supernatant was dialyzed into 
5 mM sodium-potassium phosphate, 5 mM EDTA 
(pH 7.4) with the conductivity adjusted to 1.9 msl/ 
cm with NaCl. The dialyzed plasma was then applied to 
an 8 X 50 cm column of DEAE-Sephacel (Pharmacia) 
equilibrated in the above buffer and was washed with 
6 liters of this buffer. Under these conditions the 
C3bINA was not adsorbed and eluted with the latter 
third of the IgC. The C3bINA pool, which contained 
primarily IgG and small amounts of transferrin, was 
concentrated on an Amicon PM1 0 membrane to 50 ml 
and dialyzed into 20 mM sodium-potassium phos- 
phate (pH 6.0). This pool was then applied to a 50 ml 
column of Sepharose 4B (Pharmacia) to which C3b 
had been covalently bound following cyanogen bro- 
mide activation [ 151, as in [2]. Remaining IgG was 
then removed by gel filtration of the C3bINA pool on 
Sephadex G-l 50 (Pharmacia) in 20 mM sodium-potas- 
sium phosphate, 1 M NaCl (pH 7 .O). Sodium dodecyl 
sulfate- 10% polyacrylamide gel electrophoresis 
(SDS-PAGE) [ 161 of the resulting C3bINA prepara- 
tions showed a single Coomassie blue-stained protein 
band with app. M, - 90 000 (fig.1). Under reduc- 
ing conditions, two polypeptide chains with app. 
M, 50 000 and 40 000 were present (fig.1) in agree- 
ment with [2,3,11,12]. 
C3 was isolated as in [7] and /31H was a gift from 
Dr R. A. Harrison. Column fractions during C3bINA 
isolation were monitored with a monospecific goat 
antiserum, a gift from Dr Brian Tack. C3b was pro- 
duced from isolated C3 by limited digestion with tryp- 
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Fig.1. SDS-PAGEof C3b inactivator: (1) C3bINA, unreduccd; 
(2) C3bINA, reduced; (1) is from a 10% polyacrylamide gel; 
(2) is from an SD%7% polyacrylamide gel. 
sin (0.2% trypsin/C3 ratio for 5 min at 37°C); trypsin 
was then inactivated with diisopropylphosphorofluor- 
idate (DFP) (1 mM, 60 min, 37’C). C3bINA activity 
of final preparations was confirmed by incubation of 
C3bINA (1 pg) and /31H (2 /_~g) with C3b (100 pg) for 
60 mm at 37’C. This led to complete cleavage of the 
cy’-chain of C3b to its 68 000 and 43 000 M, peptides. 
No cleavage occurred when C3b was incubated with 
either fl1H or the C3bINA alone. 
The heavy and light chains were isolated by gel 
filtration of reduced and alkylated C3bINA on 
Sepharose CL6B (Pharmacia) (3 X 170 cm) equili- 
brated in 50 mM Tris-HCl, 0.2% SDS (pH 8.0) (fig.2). 
The light chain required a second gel filtration step on 
the same column to remove remaining heavy chain. 
Samples of reduced and alkylated C3blNA and of 
the isolated polypeptide chains were hydrolyzed in 
6 M HCl for 24 h at 110°C under reduced pressure. 
Amino acids were identified on a Beckman 12 1 MB 
amino acid analyzer. No corrections were made for 
destruction of serine, threonine or tyrosine. Trypto- 
phan was not determined. Automated Edmandegrada- 
tions were performed with a Beckman 890C sequencer 
Fig.2, SDS-PAGE of the isolated C3 bINA polypeptidc chains 
(I) heavy chain; (2) light chain. Both are from a 10% poly- 
acrylamide gel. 
using a 0.1 M Quadrol program [17]. Phenylthiohy- 
dantoin derivatives of released amino acids were iden- 
tified by high-performance liquid chromatography on 
a DuPont Zorbax ODS column with gradients of ace- 
tonitrile in 10 mM sodium acetate (pH 5 S). 
3. Results and discussion 
The amino acid compositions of the C3bINA and 
of its light and heavy chains are shown in table 1. The 
composition of the intact protein reveals no apparent 
unusual characteristics, except a slightly high cysteine 
content, as noted in [3]. The composition is in good 
agreement with that in [3]. The amino acid content 
of the isolated chains likewise shows no particularly 
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Table 1 
Ammo acid composition of the C3b inactivator and its 
polypeptide chainsa 
Amino 
acid 
Content (residues/100 residues) 
C3b Inactivator Heavy chain Light chain 
- 
SCM-Cys 5.7 4.7 4.1 
Asp 11.6 11 .o 13.0 
Thr 4.8 5.2 5.0 
Ser 1.6 8.0 1.9 
Glu 11.4 12.8 1 1.7 
PI0 3.4 2.5 3.5 
Gly 9.2 8.7 11.8 
Ala 5.9 7.4 3.9 
Val 5.9 2.3 4.5 
Met 1.9 2.0 2.2 
Ile 4.5 2.9 2.5 
Leu 6.4 1.9 5.5 
Tyr 3.9 3.2 4.3 
Phe 4.0 4.6 3.8 
Lys 7.3 8 .O 1.5 
His 1.8 1.8 1.3 
ArS 4.1 5.5 4.4 
- 
a Ammo acid compositions were calculated from duplicate 
24 h hydrolysates; no corrections were made for serine and 
threonine destruction; tryptophan was not determined 
unusual features. Although the totalMr-values are too 
high for precise comparisons, the sum of the composi- 
tions of the 2 chains agree reasonably well with the 
composition of the intact protein. 
N-Terminal amino acid sequence analysis of the 
isolated C3bINA heavy chain (48 nmol) is shown in 
table 2. The repetitive yield, calculated from the leu- 
tine yields at cycles lo,16 and 23 was 96%. The 
sequence shown is not homologous with the N-termi- 
nal sequences of the active-site containing polypep- 
tide chains of other serine proteases. It also does not 
appear to be similar to the N-terminal sequences of 
either the zymogens or the non-catalytic chains of the 
serine proteases. 
Of the isolated C3bINA light chain, 48 nmol were 
subjected to 40 cycles of automated Edman degrada- 
tion (table 2). The yield at the N-terminus was only 
11% and the repetitive yield was 95%. Identical 
sequences were determined with 2 different light 
chain preparations. The amino-terminal sequence of 
the C3blNA light chain is characteristic of that of the 
serine proteases. In particular, 2 hydrophobic residues 
(isoleucine and valine) are present at the N-terminus, 
as is found at the N-terminus of the catalytic chain of 
Table 2 
N-Terminal sequences of the isolated C3b inactivator heavy 
and light chains 
Residue Heavy chain 
___ ____- 
1 Lys 
2 Val 
3 Thr 
4 Tyr 
5 Thr 
6 Ser 
I Gln 
8 Glu 
9 Asp 
10 Leu 
11 Val 
12 Gln 
13 Lys 
14 Lys 
15 Cys 
16 Leu 
17 Ala 
18 Lys 
19 Lys 
20 Tyr 
21 Thr 
22 X 
23 Leu 
24 X 
25 CYS 
26 Asp 
21 Lys 
28 Val 
29 Phe 
30 Cys 
31 Gln 
32 pro 
-__ 
Light chain 
Ile 
Val 
Gly 
GlY 
Tyr 
Val 
Ala 
Gln 
Leu 
GlY 
Phe 
Leu 
Pro 
Asn 
Tyr 
Val 
Ala 
Be 
Thr 
Tyr 
Ala 
Asn 
Asp 
Ile 
Ala 
all serine proteases. These residues in trypsin and chy- 
motrypsin are required for formation of the active 
site [ 191. Fig.3 compares the N-terminal sequences of 
several serine proteases. The strictly conserved glycine 
at position 4 and proline at position 13 are present in 
the C3bINAlight chain, in addition to other conserved 
residues. The N-terminal sequence does not appear to 
be more similar to any one of the proteases shown, 
than it is to the group as a whole. It is not more highly 
homologous with the other complement proteases, 
nor with the proteases which do not appear to have 
zymogen forms (factor D and the mast cell ‘group- 
specific’ proteases) [20-22,25-271. The C3bINA 
appears to exist in plasma in its active proteolytic 
form, and a zymogen has not been identified. The 
evolutionary relationship of the C3bINA with other 
149 
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C3b INA I V G G V V nQ L G F L P N Y VA I T Y 
Cr b chain I I G G E KA KM G N F P WE V F T N Glx 
CiT b chain IIGGSUADIKNFPWEVFFDN 
Factor D ILGGREAEAHARPVMASVQL 
Chymotrypsin IVNGEEAVPGSWPWQVSLQD 
Trypsin I V G G V T C GA NT V P V Q Y S L N S 
Plasmin V V G G C 'I A Ii P H 5 W P W Q V 5 L R T 
Factor X, I Y G G R I) C A E G E C P li Q A L L V N 
Tbrombfn I V E G 5 N A E I GM S P W Q V M L F R 
Fig.3. N-Terminal sequence of the C3bINA light chain and 
other serine proteases; Cir and Cis b chains [ 181; alternative 
complement pathway factor D [20-221; chymotrypsin A, 
trypsin, plasmin and coagulation factor X, 1231; thrombin 
[24]. The single letter amino acid code is as follows: A, ala- 
nine; C, cysteine; D, aspartic acid; E, glutamic acid; F, phenyl- 
alanine; G, glycine; H, histidine; 1, isoleucine; K, lysine; L, 
leucine; M, methionine; N, asparagine; P, proline; Q, gluta- 
mine; R, arginine; S, serine; T, threonine; V, valine; W, tryp- 
tophan; X, unknown or undetermined; Y, tyrosine. 
serine proteases will, therefore, require more complete 
structural analysis. 
These data strongly indicate that the C3blNA is a 
sefine protease. However, its proteolytic activity is 
unaffected byserine protease inhibitors [7,12,13] and 
the peptide bonds which it cleaves in C3b and C4b 
are not yet identified. Definitive identification as a 
serine protease will, therefore, require isolation and 
sequence analysis of its active-site-containing region. 
Acknowledgements 
This work was supported by US Public Health Ser- 
vice grants AM 16392 and HL 22799. 
References 
[l] Fujita, T., Gigli, I. and Nussenzweig, V. J. (1978) J. 
Exp. Med. 148,1044-1051. 
[2] Nagasawa, S., Schihara, C. and Stroud, R. M. (1980) J. 
Immunol. 125, 578-582. 
[31 
I41 
[51 
[61 
[71 
[81 
[PI 
(101 
[Ill 
[I21 
[13 I 
[14 
[I5 1 
[I61 
1171 
[I81 
[IPI 
1201 
Pll 
L221 
[231 
~241 
~251 
WI 
v71 
Pangburn, M. K., Schreiber, R. D. and Miiller-Eberhard, 
H. J. (1977) J. Exp. Med. 146, 257-270. 
Cooper, N. R. (1975) J. Exp. Med. 141,890-903. 
Law, S. K., Fearon, D. T. and Levine, R. P. (1979) J. 
Immunol. 122,759-765. 
Carlo, J. R., Ruddy, S., Studer, E. J. and Conrad, D. H. 
(1979) .I. Immunol. 123,523-528. 
Harrison, R. A. and Lachmann, P. J. (1980) Mol. Immu- 
nol. 17, P-20. 
Tamura, N. and Nelson, R. A. (1967) J. Immunol. 99, 
582-589. 
Lachmann, P. J. and Miiller-Eberhard, H. J. (1967) Prot. 
Biol. Fluids 15,469-470. 
Lachmann, P. J. and Miller-Eberhard, H. J. (1968) J. 
Immunol. 100,691-698. 
Fedron,D.T. (1977) J. Immunol. 119, 1248-1252. 
Crossley, L. G. and Porter, R. R. (1980) Biochem. J. 
191,173-182. 
Lachmann, P. J., Elias, D. E. and Moffett, A. (1972) in: 
Biological Activities of Complement (Ingram, D. G. ed) 
pp. 202-214, Karger, Basel. 
Hammer, C.H., Wirty,G. H., Renfer, L., Gresham, H.D. 
and Tack, B. F. (1981) J. Biol. Chem. 256,3995-4006. 
Pa&h, I., March, S. and Cuatrccasas, P. (1974) in: 
Affinity Techniques, Methods in Enzymology (Jakoby, 
W. B. and Wilchek, M. eds) pp. 77-102, Academic Press, 
New York. 
Laemmli, U.K. (1970) Nature 227,680-685. 
Brauer, A. W., Margolies, M. N. and Haber, E. (1975) 
Biochemistry 14, 3029-3035. 
Sim, R. B., Porter, R. R., Reid, K. B. M. and Gigli, I. 
(1977) Biochem. J. 163,219-227. 
Kraut, J. (1977) Annu. Rev. Biochcm. 46, 331-358. 
Voknakis, J. E., Bhown, A. S., Bennett, J. C. and Moles, 
J. E. (1980) Proc. Natl. Acad. Sci. USA 77, 1116-l 119. 
Johnson, D. M. A., Gagnon, J. and Reid, K. B. M. 
(1980) Biochem. J. 187,863-874. 
Davis, A. E., iii (1980) Proc. Natl. Acad. Sci. USA 77, 
4938-4942. 
De Ha&n, C. , Neurath, H. and Teller, D. C. (1975) J. 
Mol. Biol. 92,225-259. 
Elion, J., Downing, M. R., Butkowski, R. J. and Mann, 
K. G. (1977) in: Chemistry and Biology of Thrombin 
(Lundblad, R. L. et al. eds) pp. 97-l 11, Ann. Arbor 
Science, Ann. Arbor MI. 
Woodbury, R. G., Katunuma, N., Kobayashi, K., Titani, 
K. and Neurath, H. (I 978) Biochemistry 17,8 II-81 9. 
Woodbury, R. G., Evcritt, M., Sanado, Y., Katunuma, 
N., J_agunoff, D. and Neurath, H. (1978) Proc. Natl. 
Acad. Sci. USA 75,5311-5313. 
Everitt, M. T. and Neurath, II. (1979) Biochemie 61, 
65 3-662. 
150 
